Additional file 1 of Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease

Additional file 1: Figure S1. Comparison of cIMT, plasma levels of MDA, PON1 and SOD in the subjects with preserved anti-oxidative HDL capacity (HOI < 1) and impaired anti-oxidative HDL capacity (HOI ≥ 1). The differences between two groups were analyzed by independent Student’s t test and were presented as mean ± SD or median (IQR). MDA malondialdehyde; PON1 paraoxonase 1; SOD superoxide dismutase; cIMT carotid intima-media thickness. Table S1. Comparison of MDA, antioxidant enzymes, NAFLD markers and cIMT in the subjects stratified by a HOI below or above 1 and disease state. ANOVA was used to compare among four groups. Data were presented as mean ± standard deviation (SD). AST aspartate amino transferase; LS liver stiffness; cIMT carotid intima-media thickness; MDA malondialdehyde.